Influence of cytosolic and mitochondrial Ca2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid

Neurochemistry International

Volumn 43, Issue 2, 2003, Pages 89-99

  Nasr, Payman ^a   Gursahani, Hemamalini I ^b   Pang, Zhen ^a,c   Bondada, Vimala ^a   Lee, Jaewon ^a,d   Hadley, Robert W ^b   Geddes, James W ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c ROCHE BIOSCIENCE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Calcium; Calpain; Caspase; Glutamate; Necrosis

Indexed keywords

3 NITROPROPIONIC ACID; ADENOSINE TRIPHOSPHATE; CALCIUM ION; CALPAIN; CASPASE; DIZOCILPINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FETUS; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; TIME;

EID: 0344953581     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00229-2     Document Type: Article

References (56)

1. Adamec E., Beermann M.L., Nixon R.A. Calpain I activation in rat hippocampal neurons in culture is NMDA receptor selective and not essential for excitotoxic cell death. Brain Res. Mol. Brain Res. 54:1998;35-48.
2. Adamec E., Mohan P., Vonsattel J.P., Nixon R.A. Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2. Acta Neuropathol. (Berl.). 104:2002;92-104.
3. Albin R.L., Greenamyre J.T. Alternative excitotoxic hypotheses. Neurology. 42:1992;733-738.
4. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
5. 2+ network. J. Cell Biol. 136:1997;833-844.
6. Beal M.F., Hyman B.T., Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16:1993;125-131.
7. Behrens M.I., Koh J., Canzoniero L.M., Sensi S.L., Csernansky C.A., Choi D.W. 3-Nitropropionic acid induces apoptosis in cultured striatal and cortical neurons. NeuroReport. 6:1995;545-548.
8. Choi D.W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 58:1985;293-297.
9. Choi D.W. Excitotoxic cell death. J. Neurobiol. 23:1992;1261-1276.
10. Christopherson K.S., Hillier B.J., Lim W.A., Bredt D.S. PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain. J. Biol. Chem. 274:1999;27467-27473.
11. Croall D.E., DeMartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol. Rev. 71:1991;813-847.
12. 2+] and membrane potential in ventricular myocytes exposed to anoxia-reoxygenation. Am. J. Physiol. 275:1998;H484-494.
13. Desagher S., Martinou J.C. Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:2000;369-377.
14. 2+] in rat pulmonary artery smooth muscle cells. J. Physiol. 516:1999;139-147.
15. Fu Y., He F., Zhang S., Huang J., Zhang J., Jiao X. 3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum. Neurotoxicol. Teratol. 17:1995;333-339.
16. Gafni J., Ellerby L.M. Calpain activation in Huntington's disease. J. Neurosci. 22:2002;4842-4849.
17. Geddes J.W., Pang Z., Wiley D.H. Hippocampal damage and cytoskeletal disruption resulting from impaired energy metabolism. Implications for Alzheimer disease. Mol. Chem. Neuropathol. 28:1996;65-74.
18. Goffredo D., Rigamonti D., Tartari M., De Micheli A., Verderio C., Matteoli M., Zuccato C., Cattaneo E. Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. J. Biol. Chem. 277:2002;39594-39598.
19. Gottlieb R.A. Mitochondria and apoptosis. Biol. Signals Recept. 10:2001;147-161.
20. Greene J.G., Sheu S.S., Gross R.A., Greenamyre J.T. 3-Nitropropionic acid exacerbates N-methyl-D-aspartate toxicity in striatal culture by multiple mechanisms. Neuroscience. 84:1998;503-510.
21. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., Strongin A., Smith J.W., Liddington R.C., Lipton S.A. S-Nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science. 297:2002;1186-1190.
22. Hamilton B.F., Gould D.H. Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol. 72:1987;286-297.
23. Hodgson J.G., Agopyan N., Gutekunst C.A., Leavitt B.R., LePiane F., Singaraja R., Smith D.J., Bissada N., McCutcheon K., Nasir J., Jamot L., Li X.J., Stevens M.E., Rosemond E., Roder J.C., Phillips A.G., Rubin E.M., Hersch S.M., Hayden M.R. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron. 23:1999;181-192.
24. Ikonomidou C., Turski L. Neurodegenerative disorders: clues from glutamate and energy metabolism. Crit. Rev. Neurobiol. 10:1996;239-263.
25. Janicke R.U., Ng P., Sprengart M.L., Porter A.G. Caspase-3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem. 273:1998;15540-15545.
26. Keller J.N., Guo Q., Holtsberg F.W., Bruce-Keller A.J., Mattson M.P. Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production. J. Neurosci. 18:1998;4439-4450.
27. Kim G.W., Copin J.C., Kawase M., Chen S.F., Sato S., Gobbel G.T., Chan P.H. Excitotoxicity is required for induction of oxidative stress and apoptosis in mouse striatum by the mitochondrial toxin, 3-nitropropionic acid. J. Cereb. Blood Flow Metab. 20:2000;119-129.
28. Kruman I., Mattson M.P. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J. Neurochem. 72:1999;529-540.
29. Lee W.T., Itoh T., Pleasure D. Acute and chronic alterations in calcium homeostasis in 3-nitropropionic acid-treated human NT2-N neurons. Neuroscience. 113:2002a;699-708.
30. Lee W.T., Yin H.S., Shen Y.Z. The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-D-aspartate glutamate receptors and mitochondrial calcium overload. Neuroscience. 112:2002b;707-716.
31. Melloni E., Michetti M., Salamino F., Pontremoli S. Molecular and functional properties of a calpain activator protein specific for μ-isoforms. J. Biol. Chem. 273:1998;12827-12831.
32. Melloni E., Minafra R., Salamino F., Pontremoli S. Properties and intracellular localization of calpain activator protein. Biochem. Biophys. Res. Commun. 272:2000;472-476.
33. Nath R., Raser K.J., McGinnis K., Nadimpalli R., Stafford D., Wang K.K. Effects of ICE-like protease and calpain inhibitors on neuronal apoptosis. NeuroReport. 8:1996a;249-255.
34. Nath, R., Raser, K.J., Stafford, D., Hajimohammadreza, I., Posner, A., Allen, H., Talanian, R.V., Yuen, P., Gilbertsen, R.B., Wang, K.K., 1996b. Non-erythroid α-spectrin breakdown by calpain and interleukin 1 β-converting enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis, Biochem. J. 319, 683-690.
35. Newcomb J.K., Pike B.R., Zhao X., Hayes R.L. Concurrent assessment of calpain and caspase-3 activity by means of western blots of protease-specific spectrin breakdown products. Methods Mol. Biol. 144:2000;219-223.
36. Novelli A., Reilly J.A., Lysko P.G., Henneberry R.C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451:1988;205-212.
37. Pang Z., Geddes J.W. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17:1997;3064-3073.
38. Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., Greenamyre J.T. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5:2002;731-736.
39. Peng T.I., Greenamyre J.T. Privileged access to mitochondria of calcium influx through N-methyl-D-aspartate receptors. Mol. Pharmacol. 53:1998;974-980.
40. Peng T.I., Jou M.J., Sheu S.S., Greenamyre J.T. Visualization of NMDA receptor-induced mitochondrial calcium accumulation in striatal neurons. Exp. Neurol. 149:1998;1-12.
41. Pubill D., Verdaguer E., Canudas A.M., Sureda F.X., Escubedo E., Camarasa J., Pallas M., Camins A. Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. Br. J. Pharmacol. 132:2001;693-702.
42. 2+ with recombinant targeted aequorin: significance for the regulation of pyruvate dehydrogenase activity. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5489-5494.
43. Sattler R., Charlton M.P., Hafner M., Tymianski M. Distinct influx pathways, not calcium load, determine neuronal vulnerability to calcium neurotoxicity. J. Neurochem. 71:1998;2349-2364.
44. Sattler R., Xiong Z., Lu W.Y., Hafner M., MacDonald J.F., Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 284:1999;1845-1848.
45. Schulz J.B., Matthews R.T., Klockgether T., Dichgans J., Beal M.F. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol. Cell Biochem. 174:1997;193-197.
46. 2+ concentration in living cells. J. Bioenerg. Biomembr. 26:1994;487-493.
47. Tompa P., Mucsi Z., Orosz G., Friedrich P. Calpastatin subdomains A and C are activators of calpain. J. Biol. Chem. 277:2002;9022-9026.
48. 2+ transients during the contractile cycle in adult rabbit cardiac myocytes. Biochem. Biophys. Res. Commun. 236:1997;738-742.
49. Turski L., Turski W.A. Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology. Experimentia. 49:1993;1064-1072.
50. Tymianski M., Charlton M.P., Carlen P.L., Tator C.H. Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J. Neurosci. 13:1993;2085-2104.
51. Wang K.K., Posmantur R., Nadimpalli R., Nath R., Mohan P., Nixon R.A., Talanian R.V., Keegan M., Herzog L., Allen H. Caspase-mediated fragmentation of calpain inhibitor protein calpastatin during apoptosis. Arch. Biochem. Biophys. 356:1998;187-196.
52. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., Poirier G.G., Dawson T.M., Dawson V.L. Mediation of poly(ADP-rilbose) poymerase-1-dependent cell death by apoptosis-inducing factor. Science. 297:2002;259-263.
53. Zeevalk G.D., Derr-Yellin E., Nicklas W.J. NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J. Neurochem. 64:1995a;455-458.
54. Zeevalk G.D., Derr-Yellin E., Nicklas W.J. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J. Pharmacol. Exp. Ther. 275:1995b;1124-1130.
55. Zhang J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 263:1994;687-689.
56. Zhu L.P., Yu X.D., Ling S., Brown R.A., Kuo T.H. Mitochondrial Ca(2+) homeostasis in the regulation of apoptotic and necrotic cell deaths. Cell Calcium. 28:2000;107-117.